Merck Is Counting On Keytruda To Establish Its Anti-TIGIT Drug

 
• By Joseph Haas
RAHWAY, NJ - JULY 17: A sign at the entrance to a Merck plant in Rahway, New Jersey on July 17, 2017. Merck is an American pharmaceutical company.
Merck thinks its anti-TIGIT candidate will benefit from combination with Keytruda

More from ASCO

More from Conferences